These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37157841)

  • 1. Promising strategies for improving oral bioavailability of poor water-soluble drugs.
    Rocha B; de Morais LA; Viana MC; Carneiro G
    Expert Opin Drug Discov; 2023 Jun; 18(6):615-627. PubMed ID: 37157841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanonization techniques to overcome poor water-solubility with drugs.
    Da Silva FLO; Marques MBF; Kato KC; Carneiro G
    Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
    Cherniakov I; Domb AJ; Hoffman A
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 7. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.
    Mahmood T; Sarfraz RM; Ismail A; Ali M; Khan AR
    Assay Drug Dev Technol; 2023; 21(2):65-79. PubMed ID: 36917562
    [No Abstract]   [Full Text] [Related]  

  • 9. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs.
    Murakami T; Bodor E; Bodor N
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):555-580. PubMed ID: 33703995
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
    Silva AC; Santos D; Ferreira D; Lopes CM
    Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
    Wang XQ; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability Improvement Strategies for Poorly Water-Soluble Drugs Based on the Supersaturation Mechanism: An Update.
    Yang M; Gong W; Wang Y; Shan L; Li Y; Gao C
    J Pharm Pharm Sci; 2016; 19(2):208-25. PubMed ID: 27518171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review.
    Zhou Y; Du J; Wang L; Wang Y
    J Nanosci Nanotechnol; 2017 Jan; 17(1):18-28. PubMed ID: 29616786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update.
    Han J; Wei Y; Lu Y; Wang R; Zhang J; Gao Y; Qian S
    Expert Opin Drug Deliv; 2020 Oct; 17(10):1411-1435. PubMed ID: 32683996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
    Kumar S; Gupta SK
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs.
    Bazzo GC; Pezzini BR; Stulzer HK
    Int J Pharm; 2020 Oct; 588():119741. PubMed ID: 32783978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
    Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
    Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability enhancement strategies: basics, formulation approaches and regulatory considerations.
    Beg S; Swain S; Rizwan M; Irfanuddin M; Malini DS
    Curr Drug Deliv; 2011 Nov; 8(6):691-702. PubMed ID: 21864253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems.
    Boyd BJ; Bergström CAS; Vinarov Z; Kuentz M; Brouwers J; Augustijns P; Brandl M; Bernkop-Schnürch A; Shrestha N; Préat V; Müllertz A; Bauer-Brandl A; Jannin V
    Eur J Pharm Sci; 2019 Sep; 137():104967. PubMed ID: 31252052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.